heart disease

Move over big pharma. When it comes to improving the lives of patients with chronic diseases like type-2 diabetes and heart failure, the pharmaceutical industry is playing an ever smaller role.  New blockbuster drugs are the lifeblood for pharmaceutical companies.  Traditionally, they spend big advertising dollars to create consumer awareness with the goal of influencing drug choice.  But when it comes to innovation for major chronic conditions like type 2 diabetes and heart disease, pharma companies need a lifeline.   Innovation pipeline is weak There’s nothing really new coming down the pharma pipeline for diabetes or heart disease - I mean [...]